P2.01-57 Prognostic Implication of Clinical, Imaging, and Pathologic Parameters in N2(+) Stage IIIA Lung Cancer Patients

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.1111
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Choice of Postoperative Radiation for Stage IIIA Pathologic N2 Non-Small Cell Lung Cancer: Impact of Metastatic Lymph Node Number

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2017English

Role of Postoperative Radiotherapy in Pathologic Stage IIIA (N2) Non–Small Cell Lung Cancer in a Prospective Nationwide Oncology Outcomes Database

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2017English

P2.01-113 Prognostic Roles of Neoadjuvant and Adjuvant Chemotherapy for Treating Patients With Operable Stage III-N2 Non-Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Optimal Managements of Stage IIIA (N2) Non-Small Cell Lung Cancer Patients: A Population-Based Survival Analysis

Journal of Thoracic Disease
PulmonaryRespiratory Medicine
2017English

Tri-Modality Treatment in N2 Stage IIIa Non-Small Cell Lung Cancer: Proper Sequence Remains Unknown

Journal of Thoracic Disease
PulmonaryRespiratory Medicine
2018English

Prognostic Value of Number of Negative Lymph Node in Patients With Stage II and IIIa Non-Small Cell Lung Cancer

Oncotarget
Oncology
2017English

Postoperative Radiotherapy for Resected Stage IIIA–N2 Non-Small-Cell Lung Cancer: A Review of Outcomes

Hong Kong Journal of Radiology
Nuclear MedicineRadiologyImaging
2018English

P2.01-024 Prognostic Value of Body Fat Mass Ratio in Lung Cancer Patients

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2017English

P2.01-47 Clinical Outcome After Surgical Resection of Clinical Single-Station N2 Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy